List view / Grid view
13 January 2016 | By Victoria White
The discovery, made by BUSM scientists, may lead to a better understanding of the disease, early diagnosis and therapeutic development...
8 January 2016 | By Victoria White
The partnership will focus on the delivery of recombinant Glial Cell Line-Derived Neurotrophic Factor to affected brain regions by way of implanted, encapsulated cell therapy devices...
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
7 December 2015 | By Victoria White
Parkinson’s disease researchers at the University at Buffalo have developed a way to ramp up the conversion of skin cells into dopamine neurons...
19 November 2015 | By Victoria White
Scientists have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue...
10 November 2015 | By Victoria White
In preclinical studies, researchers showed that PXT-864, a combination of baclofen and acamprosate, improved multiple endpoints associated with the development and progression of Parkinson's disease...
20 October 2015 | By Victoria White
Researchers found that when HIFalpha was ‘switched off’, nerve function in flies with Parkinson’s disease was restored...
9 October 2015 | By Victoria White
Researchers reported that treatment with IFNβ-gene therapy successfully prevented neuronal death and disease effects in an experimental model of the disease...
11 September 2015 | By Victoria White
Researchers have discovered why long-term use of levodopa, a treatment for Parkinson's disease, commonly leads to a movement problem called dyskinesia...
27 July 2015 | By Victoria White
Biogen and the Parkinson’s Institute have entered a strategic alliance focused on enhancing the understanding of the underlying biology of Parkinson’s...
17 July 2015 | By Victoria White
Scientists have found that existing anti-malaria drugs, Chloroquine and Amodiaquine, could be a potential treatment for Parkinson's disease...
25 June 2015 | By Victoria White
Researchers have grown the types of neurons affected by Parkinson's disease, starting from neuronal stem cells in a three-dimensional cell culture system...
